Non-alcoholic Fatty Liver Disease (NAFLD) Market Size 2023: Epidemiology, Industry Overview, Growth, Trends, Opportunities and Forecast to 2033

IMARC Group has recently released a report titled “Non-alcoholic Fatty Liver Disease (NAFLD) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033” that presents a comprehensive assessment of the non-alcoholic fatty liver disease (NAFLD) market size, latest trends, and growth forecast. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends.

Non-alcoholic fatty liver disease (NAFLD) represents a medical ailment that is distinguished by an excess of fat deposited in liver cells. It is mainly categorized into non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). Non-alcoholic fatty liver disease includes some of the common symptoms, such as pain in the upper right side of the abdomen, liver malfunction, fluid and swelling in the stomach and legs, a dull right upper quadrant abdominal discomfort, loss of weight, etc.

A liver ultrasound scan or magnetic resonance imaging (MRI) can be utilized to identify metabolic derangements. A liver biopsy is then performed to assist in the diagnosis and differentiation of both kinds of NAFLD (including NAFL and NASH) from other types of liver disease. These specific diagnostics are followed by blood tests, which also contribute to validating the diagnosis.

Request a Free Sample Report: https://www.imarcgroup.com/non-alcoholic-fatty-liver-disease-market/requestsample

Market Trend:

The elevating prevalence of diabetes and obesity on account of the changing dietary patterns and sedentary lifestyles of consumers is primarily augmenting the non-alcoholic fatty liver disease (NAFLD) market. In addition to this, several technological advancements related to genetic testing for early and effective disease diagnosis are further propelling the market growth.

Moreover, the governing agencies of numerous countries, along with non-governmental organizations (NGOs), are supporting various health education campaigns to generate awareness regarding the risk factors of liver-related disorders, including non-alcoholic fatty liver disease, which is positively influencing the market growth. Apart from this, the introduction of innovative imaging modalities for assessing fatty liver and fibrosis, such as magnetic resonance imaging-derived proton density fat fraction and MR elastography, is projected to fuel the growth of the non-alcoholic fatty liver disease (NAFLD) market in the coming years.

Report Period:

Base Year: 2022

Historical Period: 2017-2022

Market Forecast: 2023-2033

Countries Included:

United States

Germany

France

United Kingdom

Italy

Spain

Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario

Historical, current, and future performance of the non-alcoholic fatty liver disease (NAFLD) market

Historical, current, and future performance of various therapeutic categories in the market

Sales of various drugs across the non-alcoholic fatty liver disease (NAFLD) market

Reimbursement scenario in the market

In-market and pipeline drugs

In-Market Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/non-alcoholic-fatty-liver-disease-market

Key Questions Answered in this Report:

How has the non-alcoholic fatty liver disease (NAFLD) market performed so far and how will it perform in the coming years?

What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?

What was the country-wise size of the non-alcoholic fatty liver disease (NAFLD) market across the seven major markets in 2022 and what will it look like in 2033?

What is the growth rate of the non-alcoholic fatty liver disease (NAFLD) market across the seven major markets and what will be the expected growth over the next ten years?

What are the key unmet needs in the market?

About Us: –

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St.

Brooklyn, NY 11249, USA

Email: [email protected]

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800